Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar

Published:2019-10-24 Issue:1 Volume:34 Page:77-87
ISSN:1173-8804
Container-title:BioDrugs
language:en
Short-container-title:BioDrugs

Author:

Lerch Thomas F.,Sharpe Penelope,Mayclin Stephen J.,Edwards Thomas E.,Polleck Sharon,Rouse Jason C.,Zou Qin,Conlon Hugh D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s40259-019-00390-1.pdf

Reference23 articles.

1. Kos IA, Azevedo VF, Neto DE, Kowalski SC. The biosimilars journey: current status and ongoing challenges. Drugs Context. 2018;7:212543. https://doi.org/10.7573/dic.212543 .

2. Christl LA, Woodcock J, Kozlowski S. Biosimilars: the US regulatory framework. Annu Rev Med. 2017;68:243–54. https://doi.org/10.1146/annurev-med-051215-031022 .

3. Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg. 2004;8(2):77–89. https://doi.org/10.1007/s10227-004-0115-7 .

4. Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol. 1993;30(16):1443–53.

5. Maini RN, Feldmann M. How does infliximab work in rheumatoid arthritis? Arthritis Res. 2002;4(Suppl 2):S22–8.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infliximab biosimilar GP1111: a review of 5 years’ post-approval experience;Expert Opinion on Biological Therapy;2024-07-02

2. Production of an anti-TNFα antibody in murine myeloma cells by perfusion culture;Applied Microbiology and Biotechnology;2022-07-15

3. Analytical Similarity Assessment of Biosimilars: Global Regulatory Landscape, Recent Studies and Major Advancements in Orthogonal Platforms;Frontiers in Bioengineering and Biotechnology;2022-02-09

4. Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product;Pharmaceutical Research;2020-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3